Period Ending | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
---|
Total Revenue
|
15,767,000
|
14,461,000
|
17,576,000
|
16,108,000
| Cost of Revenue |
-
|
-
|
-
|
-
| |
Gross Profit
|
15,767,000
|
14,461,000
|
17,576,000
|
16,108,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 12,548,000 | 13,445,000 | 12,719,000 | 13,155,000 |
|
Non Recurring | 4,555,000 | 4,220,000 | 3,582,000 | 3,704,000 |
|
Others | 2,790,000 | 2,640,000 | 3,092,000 | 3,168,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
2,143,000
|
1,020,000
|
3,092,000
|
4,879,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,925,000 | 69,000 | 765,000 | 583,000 |
|
Earnings Before Interest And Taxes | 9,658,000 | 6,801,000 | 11,051,000 | 10,737,000 |
|
Interest Expense | 5,590,000 | 5,712,000 | 6,031,000 | 6,438,000 |
|
Income Before Tax | 4,068,000 | 1,089,000 | 5,020,000 | 4,299,000 |
|
Income Tax Expense | 1,006,000 | 91,000 | 1,278,000 | 967,000 |
|
Minority Interest | (126,000) | (42,000) | 28,000 | (62,000) |
|
|
|
Net Income From Continuing Ops | 3,062,000 | 998,000 | 3,742,000 | 3,332,000 | |
|
Non-recurring Events |
|
Discontinued Operations | (5,000) |
-
| 1,000 | 71,000 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
2,931,000
|
956,000
|
3,771,000
|
3,341,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
2,931,000
|
956,000
|
3,771,000
|
3,341,000
|
|